Wuhan General Group (China), Inc. announced that it has appointed Dr. Anna Leralta Morera, (Dr. Anna) as the company's chief medical officer (CMO), effective immediately. In her role as CMO, Dr. Anna will seek out and evaluate opportunities in the medical cannabis and cannabidiol (CBD) sectors. Dr. Anna has established herself as a dedicated researcher, thought leader and medical practitioner in the medical cannabis field. She is relentless in advancing the medical community's understanding of cannabis and cannabinoids and ultimately in being able to provide society with alternative options to what are now standard practices. Her research to date has focused on the safety, efficacy, and effectiveness of cannabis and cannabinoids in pain and symptom management.